Lantern Pharma Leverages AI Platform, RADR, to Develop Breakthrough Antibody Drug Conjugates (ADCs)…
Lantern will leverage its proprietary AI platform, RADR, to rapidly develop novel cryptophycin-antibody drug conjugates (ADCs), which represent…